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STUDY QUESTION:What are the consequences of inhibiting mTOR, the mechanistic target of rapamycin (mTOR), and the peroxisome
proliferator activated receptor gamma (PPARγ) and PPARδ pathways in the early post-implantation period on decidual function, embryo via-
bility and feto-placental growth in the rat?
SUMMARY ANSWER: mTOR inhibition from Days 7 to 9 of pregnancy in rats caused decidual PPARγ and PPARδ upregulation on Day 9 of
pregnancy and resulted in embryo resorption by Day 14 of pregnancy. PPARγ and PPARδ inhibition differentially affected decidual mTOR signaling
and levels of target proteins relevant to lipid histotrophic nutrition and led to reduced feto-placental weights on Day 14 of pregnancy.
WHAT IS KNOWN ALREADY: Although mTOR, PPARγ and PPARδ are nutrient sensors important during implantation, the role of
these signaling pathways in decidual function and how they interact in the early post-implantation period are unknown. Perilipin 2 (PLIN2)
and fatty acid binding protein 4 (FABP4), two adipogenic proteins involved in lipid histotrophic nutrition, are targets of mTOR and PPAR sig-
naling pathways in a variety of tissues.
STUDY DESIGN, SIZE, DURATION: Rapamycin (mTOR inhibitor, 0.75 mg/kg, sc), T0070907 (PPARγ inhibitor, 0.001 mg/kg, sc),
GSK0660 (PPARδ inhibitor, 0.1 mg/kg, sc) or vehicle was injected daily to pregnant rats from Days 7 to 9 of pregnancy and the studies were
performed on Day 9 of pregnancy (n = 7 per group) or Day 14 of pregnancy (n = 7 per group).
PARTICIPANTS/MATERIALS, SETTING, METHODS: On Day 9 of pregnancy, rat decidua were collected and prepared for western
blot and immunohistochemical studies. On Day 14 of pregnancy, the resorption rate, number of viable fetuses, crown–rump length and pla-
cental and decidual weights were determined.
MAIN RESULTS AND THE ROLE OF CHANCE: Inhibition of mTOR in the early post-implantation period led to a reduction in FABP4
protein levels, an increase in PLIN2 levels and an upregulation of PPARγ and PPARδ in 9-day-pregnant rat decidua. Most embryos were viable
on Day 9 of pregnancy but had resorbed by Day 14 of pregnancy. This denotes a key function of mTOR in the post-implantation period and
suggests that activation of PPAR signaling was insufficient to compensate for impaired nutritional/survival signaling induced by mTOR inhib-
ition. Inhibition of PPARγ signaling resulted in decreased decidual PLIN2 and FABP4 protein expression as well as in inhibition of decidual
mTOR signaling in Day 9 of pregnancy. This treatment also reduced feto-placental growth on Day 14 of pregnancy, revealing the relevance of
PPARγ signaling in sustaining post-implantation growth. Moreover, following inhibition of PPARδ, PLIN2 levels were decreased and mTOR
complex 1 and 2 signaling was altered in decidua on Day 9 of pregnancy. On Day 14 of pregnancy, PPARδ inhibition caused reduced feto-
placental weight, increased decidual weight and increased resorption rate, suggesting a key role of PPARδ in sustaining post-implantation
development.
LARGE SCALE DATA: Not applicable.
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LIMITATIONS, REASONS FOR CAUTION: This is an in vivo animal study and the relevance of the results for humans remains to be
established.
WIDER IMPLICATIONS OF THE FINDINGS: The early post-implantation period is a critical window of development and changes in
the intrauterine environment may cause embryo resorption and lead to placental and fetal growth restriction. mTOR, PPARγ and PPARδ sig-
naling are decidual nutrient sensors with extensive cross-talk that regulates adipogenic proteins involved in histotrophic nutrition and import-
ant for embryo viability and early placental and fetal development and growth.
STUDY FUNDING/COMPETING INTEREST(S): Funding was provided by the Agencia Nacional de Promoción Científica y Tecnológica
de Argentina (PICT 2014-411 and PICT 2015-0130), and by the International Cooperation (Grants CONICET-NIH-2014 and CONICET-
NIH-2017) to A.J. and T.J. The authors have no conflicts of interest.
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Introduction
Emerging evidence suggests that the mechanistic target of rapamycin
(mTOR) signaling functions as a placental nutrient sensor, regulating
placental function and fetal growth in late pregnancy (Dimasuay et al.,
2016). Placental mTOR is activated in women with obesity or gesta-
tional diabetes mellitus (GDM) who deliver large babies and in animal
models associated with fetal overgrowth (Gaccioli et al., 2013; Jansson
et al., 2013; Capobianco et al., 2016; Perez-Perez et al., 2013). In con-
trast, intrauterine growth restriction (IUGR) is characterized by inhibition
of placental mTOR signaling in humans (Roos et al., 2007; Chen et al.,
2015) and in animal models (Rosario et al., 2011; Kavitha et al., 2014).
mTOR is a serine/threonine kinase that is activated by increased
nutrient levels and growth factor signaling, thereby regulating gene
transcription and protein translation to control multiple cellular pro-
cesses that promote cell metabolism, growth and survival (Laplante
and Sabatini, 2013; Shimobayashi and Hall, 2014). mTOR forms two
protein complexes, mTORC1 and mTORC2, in association with rap-
tor or rictor, respectively (Shimobayashi and Hall, 2014). Ribosomal
protein S6 (rpS6) and 4E-binding protein 1 (4E-BP1) are downstream
effectors of mTORC1 activation that positively regulate protein syn-
thesis (Shimobayashi and Hall, 2014). 4E-BP1 phosphorylation induces
the release of the eukaryotic initiation factor 4E (elF4E), activating pro-
tein synthesis and cell growth (Laplante and Sabatini, 2013). mTORC2
phosphorylates a number of targets, including serum and glucocorticoid-
inducible kinase 1 (SGK-1), with important roles in implantation (Lou
et al., 2017). Although mTOR signaling has been implicated in regulating
implantation and trophoblast and embryo growth (Martin et al., 2003;
Gardner and Harvey, 2015), the function of mTOR signaling in the early
post-implantation period remains to be determined.
In the post-implantation period, the decidua plays a fundamental
nutritional role, providing histotrophic nutrition to allow embryo sur-
vival until the formation of a mature placenta (Burton et al., 2010;
Filant and Spencer, 2014). In murine embryos, the inverted yolk sac is
crucial in histotrophic nutrition, as it is involved in the processes of
endocytosis and pinocytosis of secretions from the uterine glands and
decidual secretions (Holson et al., 2005; Zohn and Sarkar, 2010).
Lipoprotein particles are internalized in the yolk sac through the multi-
ligand endocytic receptor complex for further repackage of lipids and
transfer to the embryo (Herz and Farese, 1999; Zohn and Sarkar,
2010). The secretions from decidual cells and endometrial glands are
rich in lipid droplets (Burton et al., 2007). Lipid droplets are character-
ized by the presence of the adipogenic protein perilipin 2 (PLIN2),
which is considered a marker for the lipid load of non-adipogenic cells
(Heid et al., 1998). PLIN2 is transcriptionally regulated by peroxisome
proliferator activated receptor γ (PPARγ) and PPARδ in trophoblasts
and other cell types (Bildirici et al., 2003; Tobin et al., 2006). In addition,
fatty acid binding protein 4 (FABP4), a protein involved in intracellular
and transcellular lipid transfer and relevant for decidual function (Tian
et al., 2011), is transcriptionally regulated by PPARγ (Tan et al., 2002).
PPARs are transcription factors activated by ligands of lipid nature
(e.g. mono- and polyunsaturated fatty acids) that function as master
transcription factors to regulate gene expression in metabolic processes,
critically important in maintaining lipid homeostasis and antioxidant/anti-
inflammatory responses (Wahli and Michalik, 2012). Besides, they play
relevant roles in embryo organogenesis and feto-placental development
and metabolism (Jawerbaum and Capobianco, 2011; Kadam et al., 2015;
Lendvai et al., 2016). There are three PPAR isoforms, and among which,
PPARγ and PPARδ play key roles in adipogenesis and are essential for
embryo development (Barak et al., 2008; Barquissau et al., 2017; Wahli
and Michalik, 2012). Indeed, there are specific placental developmental
defects in PPARγ and PPARδ null mice, which lead to embryo death, sug-
gesting that both isoforms are essential and the absence of compensatory
effects by other PPAR isoforms that rescue the adverse phenotype
(Wang et al., 2007; Barak et al., 2008). Our previous studies showed
reduced embryonic PPARδ and decidual PPARγ in diabetic rats during
early organogenesis, changes associated with impaired embryo morpho-
genesis (Higa et al., 2010, 2014). Moreover, changes in fatty acid meta-
bolism involve extensive PPAR and mTOR cross-talk in a variety of cell
types (Ishiguro et al., 2006; Blanchard et al., 2012; Angela et al., 2016)
and these nutrient signaling pathways share targets such as FABP4
(Wang et al., 2017). In the current study, we hypothesized that there
is a cross-talk between mTOR, PPARγ and PPARδ in the decidua that
impacts post-implantation embryo survival and feto-placental growth.
To test this hypothesis, we determined the effects of pharmacological
inhibition of mTOR, PPARγ and PPARδ signaling during the early post-
implantation period in pregnant rats.
Materials andMethods
Animals
Albino Wistar rats were obtained from the certified animal facility of the
School of Exact and Natural Sciences, University of Buenos Aires (UBA,
Argentina). In our animal facility (CEFYBO-CONICET, UBA, Argentina),
rats received water and food ad libitum (commercial rat chow, Asociación
Cooperativa Argentina, Buenos Aires, Argentina), on a lighting cycle of
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12 h light:12 h dark. The animal protocol was approved by the Institutional
Committee for the Care and Use of Experimental Animals (CICUAL,
Resolution CD No. 1497/2013), School of Medicine, University of Buenos
Aires, and conducted according to the Guide for the Care and Use of
Laboratory Animals, US National Institutes of Health (NIH Publication, 8th
edition, 2011) http://www.ncbi.nlm.nih.gov/books/NBK54050/?report=
reader. Females were mated and mating was confirmed by the presence of
sperm in vaginal smears and this day was designated Day 1 of pregnancy.
Pregnant females received three daily sc injections beginning on Day 7 of
pregnancy: receiving either (i) rapamycin (mTOR inhibitor, 0.75 mg/kg, LC
Laboratories, Massachusetts, USA); (ii) T0070907 (PPARγ inhibitor,
0.001 mg/kg, Sigma Aldrich, Missouri, USA); (iii) GSK0660 (PPARδ inhibi-
tor, 0.1 mg/kg, Sigma Aldrich, Missouri, USA) or (iv) vehicle (control). The
doses of the inhibitors used were chosen based on bibliography and pre-
liminary experiments (Lee et al., 2002; Harston et al., 2011; Tsai et al.,
2014). The dosing interval was chosen aiming to address an early and pre-
somite embryo post-implantation stage in which the decidua is crucial for
embryo development and nutrition. Half of the animals were euthanized in
a CO2 chamber on Day 9 of pregnancy (3 h after the last injection) and the
remainder on Day 14 of pregnancy. Using a stereomicroscope and micro-
surgical dissecting instruments, the balls of decidual tissue were explanted
from each uterus on Day 9 of pregnancy (n = 7 dams in each experimental
group). The decidua were prepared for immunohistochemical analyses of
the levels of FABP4 and PLIN2, or homogenized in ice-cold buffer D
(250 mM sucrose, 10 mM Hepes-Tris, pH 7.4) with protease inhibitor
cocktail and phosphatase inhibitor cocktails 2 and 3 (Sigma Aldrich,
Missouri, USA) and stored at −80°C for western blot analysis of PPARγ,
PPARδ and functional readouts of the mTOR pathway. Decidua, fetuses
and placentas from 14-day pregnant rats (n = 7 dams in each experimental
group) were explanted from each uterus, examined morphologically under
a stereomicroscope and weighed.
Immunohistochemistry
Immunostaining of FABP4 and PLIN2 was performed in the decidua of
9-day pregnant rats (n = 7 in each experimental group). Each decidua was
paraffinized and serially sectioned (5 μm). Sections were deparaffinized,
rehydrated through a graded series of ethanol and the endogenous perox-
idase activity was blocked. The sections were processed using the corre-
sponding primary antibodies: anti-FABP4 (rabbit polyclonal antibody
(GTX54016), 1:100 dilution, GeneTex, CA, USA), and anti-PLIN-2
(mouse monoclonal antibody (LS-C348703 clone AP125), 1:100 dilution,
LifeSpan BioSciences, Washington, USA). All primary antibodies were
checked for antibody specificity by Western blot and diluted in PBS-
Tween with 1% bovine serum albumin (BSA). Negative controls were per-
formed in the absence of primary antibody and by replacing the primary
antibody by a pooled serum of the same species that contains a spectrum
of the IgG subclasses (Vector Laboratories, Burlingame, CA, USA).
Biotinylated antibodies (anti-rabbit IgG or anti-mouse IgG-rat absorbed),
1:200 PBS-Tween in 1.5% normal horse serum (Vector Laboratories,
Burlingame, CA, USA), were applied, followed by an incubation with an avi-
din–biotin complex for 60 min (Vector Laboratories). Staining was visualized
by adding 40% w/v 3,3′-diaminobenzidine tetrahydrochloride chromogen-
buffer plus 0.02% (v/v) hydrogen peroxide in 0.05M Tris (pH 7.6) for 10 min
(Martinez et al., 2012). Three entire sections per decidua were examined
using light microscopy by two skilled blinded observers. Immunoreactivity
intensity was quantified using the ImageProPlus software. Data are shown as
relative to a value of 1, arbitrarily assigned to the control. We also performed
a semiquantitative score, which led to similar results (data not shown). In
addition, also in the yolk sac and the uterine glands a semiquantitative score
was performed.
Western blot analysis
Proteins from homogenates of pooled decidua from the same litter (n = 7
rats in each experimental group) were separated by SDS-PAGE and trans-
ferred to PVDF membranes (35 V constant, overnight at 4°C), as previ-
ously described (Capobianco et al., 2016). The membranes were stained
with Ponceau S staining solution for total proteins (Sigma-Aldrich) to con-
firm equal loading and transfer. Blocking was carried out for 1 h at room
temperature in 1% BSA in TBS-Tween and membranes were incubated
with the primary antibody (diluted in 1% BSA in TBS-Tween) overnight at
4°C. Protein expression of total and phosphorylated rpS6, total and phos-
phorylated 4E-BP1 was determined using antibodies (monoclonal 2217
clone 5G10 and polyclonal 2211, 9452 and 9459, respectively) from Cell
Signaling Technology (Massachusetts, USA). Total and phosphorylated
SGK-1 was evaluated using polyclonal antibodies (AF3200) from RyD
Systems (Minnesota, USA) and (SC16745) from Santa Cruz (Texas, USA),
respectively. PLIN2 was determined using antibodies from LifeSpan
BioSciences (LS-C348703 clone AP125), while protein expression of
PPARγ and PPARδ was determined using polyclonal antibodies (101 700
and 101 720, respectively) from Cayman Chemical Company, Michigan,
USA. After washing, the membranes were incubated with the appropriate
peroxidase conjugated secondary antibody and visualized using ECL detec-
tion solution (Thermo Scientific) and captured in a Chemiluminescence
imaging system (GeneGnomeXRQ, Syngene). Densitometry analysis was
performed with ImageJ software (Schneider et al., 2012). The expression
of the target protein in each individual lane was normalized for total pro-
tein staining to adjust for unequal loading. The mean of all the samples
within a single gel was calculated and the expression of the target protein
in each sample was calculated as a percentage of that mean (target/total
protein).
Statistical analysis
Data are presented as the mean ± SEM. Groups were compared by
Student t test or Chi-square test as appropriate. A P < 0.05 was con-
sidered statistically significant.
Results
Effects of inhibition of mTOR signaling in the
early post-implantation period
Aiming to address the impact of mTOR inhibition limited to an early
post-implantation period, rapamycin (0.75 mg/kg, sc) was adminis-
tered to pregnant rats on Days 7, 8 and 9 of pregnancy and the
decidua were evaluated 3 h after the last injection on Day 9 of preg-
nancy. Rapamycin administration led to more than 50% reduction in
the phosphorylation of downstream targets of mTORC1 (rpS6 and
4E-BP1) and mTORC2 (SGK-1) in the decidua (Supplementary
Fig. S1). We determined the protein expression of FABP4 and found
that the inhibition of mTOR signaling resulted in a 22% reduction of
FABP4 levels in the decidua (P < 0.05), when compared to control
rats (Fig. 1). A similar pattern of expression was observed in decidual
cells and in the uterine glands, although only a weak staining, which
did not change with the rapamycin treatment, was observed in the
yolk sac (Fig. 1). We next evaluated the protein expression of PLIN2
and found that the inhibition of mTOR signaling resulted in a 25%
increase in decidual PLIN2 levels (P < 0.01) when compared to con-
trols (Fig. 1). This increase was also observed when PLIN2 protein
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Figure 1 Effect of in vivo treatments with the mTOR inhibitor rapamycin during Days 7–9 of pregnancy on decidual protein levels of (a) FABP4, (b)
PLIN2, (c) PPARγ and (d) PPARδ, evaluated on Day 9 of pregnancy. Values represent mean ± SEM obtained from seven rats in each experimental group.
Statistical analysis: Student t test. *P < 0.05, **P < 0.01 and ***P < 0.001 versus control. Representative photos of FABP4 and PLIN2 in the decidua, yolk sac
and uterine glands are shown. D, decidua. E, embryo. White arrows point to the yolk sac. Black arrows point to immunostained uterine gland cells.
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levels were determined by western blot analysis (Supplementary
Fig. S2). Different from decidual cells, only a weak PLIN2 staining
was observed in the uterine glands, although the yolk sac showed a
strong PLIN2 staining, which increases when mTOR signaling was
inhibited (Fig. 1). As PLIN2 is a classical PPAR target involved in the
formation of lipid droplets (Heid et al., 1998; Bildirici et al., 2003),
and mTOR and PPAR cross-talk has been described in different tis-
sues/cell types (Blanchard et al., 2012; Angela et al., 2016), we next
measured the protein expression of PPARγ and PPARδ. We
observed that mTOR inhibition caused an increase in the protein
levels of both PPARγ (36%, P < 0.05) and PPARδ (87%, P < 0.001)
in the decidua (Fig. 1).
Effects of inhibition of PPARγ signaling in the
early post-implantation period
To next address the effect of PPARγ inhibition limited to an early post-
implantation stage, the PPARγ inhibitor T0070907 (0.001 mg/kg, sc)
was administered to rats on Days 7–9 of pregnancy and the decidua
were evaluated on Day 9 of pregnancy. PPARγ inhibition led to a
decrease in the protein levels of FABP4 (40%) in the decidua when
compared to controls (P < 0.01, Fig. 2). A reduced FABP4 expression
was also observed in the uterine glands, although only a weak staining
was observed in the yolk sac in both the control and the PPARγ inhib-
ited groups (Fig. 2). The inhibition of PPARγ led to a decrease in the
Figure 2 Effect of in vivo treatments with the PPARγ inhibitor T0070907 during Days 7–9 of pregnancy on decidual protein levels of (a) FABP4 and
(b) PLIN2, evaluated on Day 9 of pregnancy. Values represent mean ± SEM obtained from seven rats in each experimental group. Statistical analysis:
Student t test. **P < 0.01 versus control. Representative photos of FABP4 and PLIN2 in the decidua, yolk sac and uterine glands are shown. D, decidua.
E, embryo. White arrows point to the yolk sac. Black arrows point to immunostained uterine gland cells.
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protein levels of PLIN2 (51%) in the decidua when compared to con-
trols (P < 0.01, Fig. 2). A decrease was also evidenced when decidual
PLIN2 protein levels were determined by western blot analysis
(Supplementary Fig. S2). In contrast to decidual cells, only a weak
PLIN2 staining was observed in the uterine glands from the control
and the PPARγ inhibited group. Similarly to decidual cells, PLIN2 levels
were reduced in the yolk sac when PPARγ was inhibited (Fig. 2). In
addition, PPARγ inhibition decreased the phosphorylation of rpS6 (P <
0.01) by a 25% without affecting total rpS6 levels in the decidua,
whereas it did not change the levels of total and phosphorylated 4E-
BP1 compared to controls (Fig. 3). Moreover, we observed a marked
reduction of phosphorylated SGK-1 (50%, P < 0.01), despite unchanged
total SGK-1 levels in the decidua from T0070907-treated pregnant rats
compared to controls (Fig. 3). Collectively, these data demonstrate that
inhibition of decidual PPARγ inhibits mTORC1 and mTORC2 signaling.
Effects of inhibition of PPARδ signaling in the
early post-implantation period
To address the effect of PPARδ inhibition limited to an early post-
implantation period, the PPARδ inhibitor GSK0660 (0.1 mg/kg, sc)
was administered to rats on days 7 to 9 of pregnancy and the decidua
were evaluated on Day 9 of pregnancy. PPARδ inhibition did not alter
decidual FABP4 protein levels compared to controls (Fig. 4). Similarly,
PPARδ inhibition did not change FABP4 levels in the uterine glands
(Fig. 4). Only a weak FABP4 staining was detected in the yolk sac from
rats treated or not with the PPARδ inhibitor (Fig. 4). The inhibition of
PPARδ led to a decrease in the protein levels of PLIN2 (37%) in the
decidua when compared to controls (P < 0.01, Fig. 4). A similar
decrease was evidenced when decidual PLIN2 levels were determined
by western blot analysis (Supplementary Fig. S2). In the uterine glands,
only a weak PLIN2 staining was observed in both the control and the
PPARδ inhibited groups (Fig. 4). Differently, the yolk sac showed a
strong PLIN2 staining, which diminished when PPARδ was inhibited,
similarly to that observed in decidual cells (Fig. 4).
With respect to cross-talk with mTOR pathways, PPARδ inhibition
did not affect the total expression or phosphorylation of rpS6 in the
decidua, but markedly increased 4E-BP1 phosphorylation by a 73% (P <
0.001, Fig. 5) compared to controls, without affecting the total levels of
this protein, suggesting the activation of this branch of the mTORC1 sig-
naling pathway. In contrast, decidual levels of phosphorylated SGK-1
were found to be reduced by 53% (P < 0.001, Fig. 5) following PPARδ
inhibition, whereas no changes in the levels of total SGK-1 were
observed, suggesting the inhibition of the mTORC2 signaling pathway.
Effects of mTOR and PPAR signaling
inhibition on resorption rates and growth
capacity
The number of viable embryos and the resorption rate on Day 9 of
pregnancy were similar in the control rats and in the rats that received
the mTOR inhibitor (rapamycin 0.75 mg/kg, sc) from Days 7 to 9 of
pregnancy (Fig. 6). To further assess the effects of mTOR inhibition in
the early post-implantation period on embryo viability and growth
capacity, we evaluated the conceptus on Day 14 of pregnancy follow-
ing administration of vehicle (control) or the mTOR inhibitor (rapa-
mycin 0.75 mg/kg) from Days 7 to 9 of pregnancy. On Day 14 of
pregnancy, a dramatic (92%) decrease in the number of viable fetuses
per rat (P < 0.001) and an increased resorption rate (P < 0.001) were
evident in the group that received the mTOR inhibitor compared to
controls (Fig. 6). Indeed, most fetuses were resorbed, and the few
fetuses that survived to Day 14 of pregnancy displayed morphological
Figure 3 Effect of in vivo treatments with the PPARγ inhibitor
T0070907 during Days 7–9 of pregnancy on decidual protein levels of
(a) phosphorylated and total rpS6, (b) phosphorylated and total 4E-
BP1 and (c) phosphorylated and total SGK-1, evaluated on Day 9 of
pregnancy. Values represent mean ± SEM obtained from seven rats in
each experimental group. Statistical analysis: Student t test. **P < 0.01
versus control.
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alterations and a severe developmental delay likely leading to future
resorptions (Fig. 7).
In the rats that received the PPARγ inhibitor (T0070907 0.001mg/kg,
sc) from Days 7 to 9 of pregnancy, the number of viable embryos and
the resorption rate on Day 9 of pregnancy were similar to those of con-
trol rats and remained similar on Day 14 of pregnancy (Fig. 8). The inhib-
ition of PPARγ did not affect gross fetal morphology on Day 14 of
pregnancy (Fig. 7), but the reduced crown–rump length (P < 0.001)
(Fig. 8) indicated a growth delay. In addition, placental weight was mark-
edly reduced (51%, P < 0.001) following PPARγ inhibition, although
decidual weight was unchanged when compared to controls (Fig. 8).
In the rats that received the PPARδ inhibitor (GSK0660 0.1 mg/kg,
sc) from Days 7 to 9 of pregnancy, the number of viable embryos and
the resorption rate on Day 9 of pregnancy were similar to those of
control rats (Fig. 9). However, on Day 14 of pregnancy, the rats that
received the PPARδ inhibitor during the early post-implantation period
showed a reduction in the number of viable fetuses (P < 0.05) and an
increased resorption rate (P < 0.01) as compared to controls (Fig. 9).
Although there were no gross malformations on the 14-day fetuses in
the group that received the PPARδ inhibitor (Fig. 7), they were growth
restricted, as indicated by their reduced crown–rump length (P <
0.01) (Fig. 9). Furthermore, PPARδ inhibition was associated with
Figure 4 Effect of in vivo treatments with the PPARδ inhibitor GSK0660 during Days 7–9 of pregnancy on decidual protein levels of (a) FABP4 and
(b) PLIN2, evaluated on Day 9 of pregnancy. Values represent mean ± SEM obtained from seven rats in each experimental group. Statistical analysis:
Student t test. **P < 0.01 versus Control. Representative photos of FABP4 and PLIN2 in the decidua, yolk sac and uterine glands are shown. D,
decidua. E, embryo. White arrows point to the yolk sac. Black arrows point to immunostained uterine gland cells.
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reduced placental weight (35%, P < 0.01), and increased decidual
weight on Day 14 of pregnancy (35%, P < 0.001) (Fig. 9).
Discussion
Following implantation and before the mature placenta is established,
the embryo relies on histotrophic nutrition through secretions from
decidual cells and endometrial glands in both humans and rodents
(Burton et al., 2010; Filant and Spencer, 2014). In rodents, the inverted
yolk sac favors the absorption of nutrients (Zohn and Sarkar, 2010).
Although the role of placental mTOR and PPARs as nutrient sensors in
late pregnancy is established, the function of these signaling pathways
in regulating histotrophic nutrition in the early post-implantation peri-
od is largely unknown. We report for the first time that when mTOR,
PPARγ or PPARδ pathways are inhibited in the early post-implantation
period, a complex cross-talk between these signaling pathways is
observed in the decidua, leading to reduced levels of adipogenic pro-
teins relevant for histotrophic nutrition. Specifically, although inhibition
Figure 5 Effect of in vivo treatments with the PPARδ inhibitor
GSK0660 during Days 7 to 9 of pregnancy on decidual protein levels
of (a) phosphorylated and total rpS6, (b) phosphorylated and total
4E-BP1 and (c) phosphorylated and total SGK-1, evaluated on Day 9
of pregnancy. Values represent mean ± SEM obtained from seven rats
in each experimental group. Statistical analysis: Student t test. ***P <
0.001 versus control.
Figure 6 Effect of in vivo treatments with the mTOR inhibitor rapa-
mycin during Days 7–9 of pregnancy on the number of viable embryos
per rat and the resorption rate (a) on Day 9 of pregnancy and (b) on
Day 14 of pregnancy. Values represent mean ± SEM obtained from
seven rats in each experimental group. Statistical analysis: Student
t test or Chi-square test (percentage of resorption data). ***P < 0.001
versus control.
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of these nutrient sensors does not affect early post-implantation
embryo viability, it leads to embryo loss, growth delay or placental/
decidual growth impairments in mid-gestation.
There is a growing interest in understanding the first trimester of
human pregnancy, not only to improve the understanding of implant-
ation failure and miscarriage but also in the search of possible early
causes of pregnancy complications that typically are diagnosed later in
pregnancy, including gestational diabetes and IUGR (Albu et al., 2014;
Kennelly and McAuliffe, 2016). The first trimester of pregnancy is char-
acterized by histotrophic nutrition, which provides essential nutrients
to the growing embryo and allows a proper placental development
(Burton et al., 2010; Filant and Spencer, 2014). To address the impact of
nutrient sensors in the early post-implantation period, we administered
mTOR, PPARγ and PPARδ inhibitors on Days 7–9 of rat pregnancy, a
developmental stage corresponding to the very early post-implantation
embryonic and placental development that occurs in the second week of
human pregnancy. Our data reveal the importance of this early post-
implantation period in determining fetal growth and identify distinct
effects of the inhibition of mTOR, PPARγ or PPARδ signaling on decidual
proteins relevant for histotrophic nutrition.
The inhibition of mTOR limited to this short post-implantation peri-
od had a pronounced impact on mid-gestation outcomes. Indeed, the
resorption rate on Day 14 of pregnancy was extremely high and
occurred despite the observed upregulation of PPARγ and PPARδ in
the decidua, which may be compensatory. The cross-talk between
mTOR and PPARs seems to be dependent on the tissue and cell type, as
it is well described that in adipose tissue, mTOR activation stimulates
PPARγ-induced lipid uptake and fat accretion (Kim and Chen, 2004;
Blanchard et al., 2012). The increased abundance of PLIN2 protein in the
decidua is likely to be the result of PPARγ activation, given the well estab-
lished role of PPARγ as a transcriptional regulator of PLIN2 in tropho-
blasts and other cell types (Bildirici et al., 2003). In this study, PLIN2
levels were low in the uterine glands but high in the yolk sac, which show
a further increase in their levels when mTOR is inhibited, suggesting a
common regulation in the decidual cells and the yolk sac.
mTOR inhibition caused a decrease in FABP4 protein expression, in
both decidua and uterine glands, similarly to that observed in other
cell types (Wang et al., 2017), and despite PPARγ activation, which has
been reported to positively regulate FABP4 in different tissues (Tan
et al., 2002).
Although it is well established that IUGR is associated with inhibition
of placental mTORC1 and mTORC2 signaling (Roos et al., 2007;
Rosario et al., 2011; Kavitha et al., 2014; Chen et al., 2015), the sever-
ity of the phenotype observed in this work demonstrates that the early
post-implantation period is highly susceptible to mTOR inhibition,
implicating mTOR as a nutrient sensing and growth promoting signaling
pathway critical for normal development and survival at this develop-
mental stage. mTOR is important for the growth and survival of the
trophoblast and embryo prior to implantation as evidenced by the lack
of viability of mTOR null mice (Murakami et al., 2004), and impaired
trophoblast outgrowth following mTOR inhibition in pre-implantation
embryos in culture (Martin et al., 2003). These reports, together with
the findings in the present study, are consistent with a critical role of
mTOR in embryo viability from conception to the early post-
implantation stage. In addition to the well-known role of mTOR
modulating placental nutrient transport and mitochondrial respiration
and thereby regulating fetal growth (Kavitha et al., 2014), a recent
study in which rapamycin was given to rats during late pregnancy has
shown that mTOR signaling is involved in the programming of heart
defects in the offspring (Hennig et al., 2017). Moreover, placental
mTOR signaling activity in IUGR correlates with growth during the first
year of life (Fahlbusch et al., 2015). Therefore, mTOR signaling
appears to play an important role in determining growth and survival
from early pregnancy to the postnatal period.
In the present study, a less severe phenotype was observed when
PPARγ was inhibited in the early post-implantation period in the rat.
Our results are consistent with a role for PPARγ as a nutrient sensor,
capable of regulating the levels of FABP4 in the decidua and uterine
glands and the levels of PLIN2 in the decidua and yolk sac, adipogenic
proteins involved in cellular and tissue lipid metabolism (Heid et al.,
1998; Li et al., 2018; Scifres et al., 2011). As FABP4 is involved in decid-
ualization and PLIN2 modulates lipid accumulation and transfer in dif-
ferent tissues, including the placenta (Bildirici et al., 2003; Scifres et al.,
2011; Frank et al., 2015; Tian et al., 2011; Li et al., 2018), the downre-
gulation of these adipogenic proteins in the decidua, uterine glands and
yolk sac may be directly linked to the feto-placental growth restriction
observed following PPARγ inhibition. The proposed histotrophic and
growth promoting role of these adipogenic proteins in the decidua is
supported by the reported metabolic and histotrophic role of PLIN2
in tumor cell growth and the ability of FABP4 to regulate proliferation,
Figure 7 Representative figures of fetuses obtained from 14-day pregnant rats that received (a) vehicle, (b) the mTOR inhibitor rapamycin, (c) the
PPARγ inhibitor T0070907 and (d) the PPARδ inhibitor GSK0660 from Days 7 to 9 of pregnancy.
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migration and invasion of human uterine endometrial epithelial cells
(Zhu et al., 2015; Koizume and Miyagi, 2016).
Although diverse studies have shown that PPARγ activation nega-
tively regulates mTOR signaling in different tissues (San et al., 2015;
Osman and Segar, 2016; Capobianco et al., 2017), by studying the
decidua, we found that the activities of both mTORC1 and mTORC2
signaling pathways were reduced when the rats were treated with the
PPARγ inhibitor. Despite this reduction, there was no increased
resorption rate on Day 14 of pregnancy. The different outcomes in
pregnancies in which mTOR was inhibited using rapamycin (causing a
high resorption rate) and in pregnancies in which PPARγ was inhibited
(associated with mTOR inhibition but no effect on resorption rates)
may be related to a less pronounced inhibition of mTOR in rats follow-
ing PPARγ inhibition as compared to rats treated with the mTOR
inhibitor.
In rats treated with the PPARγ inhibitor during the early post-
implantation period, both the reduction in levels of adipogenic pro-
teins, which is expected to limit lipid transfer to the developing embryo
(Bildirici et al., 2003; Scifres et al., 2011), and the reduced mTOR sig-
naling, expected to inhibit transfer of amino acids and cell growth
Figure 8 Effect of in vivo treatments with the PPARγ inhibitor T0070907 during Days 7 to 9 of pregnancy on (a) the number of viable embryos per
rat and the resorption rate on Day 9 of pregnancy and (b) the number of viable fetuses per rat, the resorption rate, the fetal crown–rump length and
the placental and decidual weight on Day 14 of pregnancy. Values represent mean ± SEM obtained from seven rats in each experimental group.
Statistical analysis: Student t test or Chi-square test (percentage of resorption data). ***P < 0.001 versus control.
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(Shimobayashi and Hall, 2014; Dimasuay et al., 2016), may be involved
in the reduced fetal and placental weight evidenced in the post-
placentation period. The mechanisms linking the inhibition of critical
nutrient sensing signaling pathways on Days 7–9 of gestation to the
outcomes on Day 14 of pregnancy remain to be established but may
involve epigenetic mechanisms or effects on stem/progenitor cell
populations. Indeed, PPAR and mTOR signaling regulates epigenetic
and stem cell differentiation in different tissues/cell types, leading to
developmental and metabolic changes (Meyer et al., 2016; Vadla and
Haldar, 2018).
PPARδ inhibition in pregnant rats in the early post-implantation peri-
od caused no changes in FABP4 levels in the decidua and uterine
glands, but resulted in a reduction in PLIN2 protein levels in the
decidua and yolk sac, which may contribute to an impaired lipid histo-
trophic nutrition. To the best of our knowledge, PLIN2 has not been
previously studied in the context of decidual function, but our data are
consistent with the possibility that PLIN2 is regulated by mTOR and
PPAR nutrient sensing pathways and is involved in histotrophic nutri-
tion in early pregnancy. Indeed, the strong PLIN2 immunostaining evi-
dent in the inverted yolk sac suggests its contribution to the various
Figure 9 Effect of in vivo treatments with the PPARδ inhibitor GSK0660 during Days 7–9 of pregnancy on (a) the number of viable embryos per rat
and the resorption rate on Day 9 of pregnancy and (b) the number of viable fetuses per rat, the resorption rate, the fetal crown–rump length and the
placental and decidual weight on Day 14 of pregnancy. Values represent mean ± SEM obtained from seven rats in each experimental group. Statistical
analysis: Student t test or Chi-square test (percentage of resorption data). *P < 0.05, **P < 0.01 and ***P < 0.001 versus control.
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mechanisms described in the yolk sac that allow a proper transfer of
lipids to the developing murine embryos (Herz and Farese, 1999;
Zohn and Sarkar, 2010).
PPARδ inhibition on Days 7–9 of pregnancy resulted in increased
decidual levels of phosphorylated 4E-BP1, a branch of the mTORC1
pathway that promotes initiation of protein translation, thus leading to
increased protein synthesis. It is possible that these changes contribute
to the decidual overgrowth observed in this experimental group. On
the other hand, decidual mTORC2 signaling was inhibited following
PPARδ inhibition, which, together with the reduction of decidual
PLIN2 levels, may have detrimental effects and lead to the reduced
feto-placental growth evidenced on Day 14 of pregnancy. Moreover,
embryo resorptions were also observed in this experimental group,
highlighting an important role of PPARδ in the decidua in the early
post-implantation period. These observations extend to the early
post-implantation period the previously established critical role of
PPARδ in implantation (Wang et al., 2007).
Our results point to an impaired nutritional effect in the decidua, which
leads to the adverse results observed in embryo and placental develop-
ment. Nevertheless, as a limitation of this work, it is unknown whether
some of these effects are secondary to systemic (endocrine) effects in the
mother. Moreover, as PPARs and mTOR pathways are involved in angio-
genic pathways in the placenta and other tissues/cell types (Wang et al.,
2007; Jiang and Liu, 2008), a possible regulation of angiogenic pathways
that may be involved in the observed effects deserves further research.
Finally, further studies addressing a rescue of the phenotype through
mTOR and PPARs activation will be needed to improve the understand-
ing of mTOR and PPAR signaling in embryo organogenesis.
In conclusion, our findings are consistent with an important role of
decidual mTOR and PPAR nutrient sensing pathways in a very early
post-implantation period. Possibly by regulating histotrophic nutrition,
these nutrient sensors determine embryo viability and the growth of
the placenta and the fetus.
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